Controversies in the use of postnatal steroids

Area of Science:

• Neonatal Medicine
• Pediatric Pulmonology
• Clinical Evidence Synthesis

Background:

• Very low birth weight infants often require mechanical ventilation.
• Chronic lung disease (CLD) is a significantcomplication in these vulnerable infants.
• Postnatal steroid therapy is a potential intervention to mitigate CLD.

Purpose of the Study:

• To evaluate the risks and benefits of postnatal steroid use in very low birth weight infants.
• To compare the efficacy and safety of systemic postnatal steroids based on current medical evidence.
• To inform clinical decision-making regarding steroid administration in neonates.

Main Methods:

• Systematic review of the best available medical evidence.
• Analysis of studies comparing postnatal steroid use versus placebo or no treatment.
• Assessment of outcomes including chronic lung disease and neurologic sequelae.

Main Results:

• Systemic postnatal steroids are effective in reducing the risk of chronic lung disease in ventilated very low birth weight infants.
• Optimal timing for steroid administration appears to be between 7 to 14 days of age for ventilator-dependent infants.
• Steroid use is associated with an increased risk of long-term neurologic sequelae and short-term complications.

Conclusions:

• Postnatal steroids offer a significant benefit in reducing chronic lung disease for premature infants on ventilators.
• The increased risk of adverse neurologic outcomes necessitates careful consideration of the risk-benefit profile.
• The justification for using postnatal steroids depends on parental and caregiver perspectives regarding the trade-offs between CLD and neurologic sequelae.